热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
APC anti-human CD19 Antibody
产品名称：
APC anti-human CD19 Antibody
产品类别：
抗体
产品编号：
302211
产品应用：
302211
[价格]
规格 价格 库存
25tests ￥ 616 1

产品详情

Product Details

Verified Reactivity
Human
Reported Reactivity
Chimpanzee
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The CD19 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections8 and blocking of B cell proliferation. Clone HIB19 is not recommended for formalin-fixed paraffin-embedded sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 302267 & 302268).

?

Clone HIB19 partially blocks anti-human CD19 clones 4G7 and SJ25C1 staining based on in-house testing

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  3. Bradbury L, et al. 1993. J. Immunol. 151:2915.
  4. Joseph A, et al. 2010. J. Virol. 84:6645. PubMed
  5. Wang X, et al. 2010. Haematologica. 95:884. (FC) PubMed
  6. Walker JD, et al. 2009. J. Immunol. 182:1548. (Block) PubMed
  7. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  8. Hansen A, et al. 2002. Arthritis Rheum. 46:2160. (IHC)
  9. Stoeckius M, et al. 2017. Nat. Methods. 14:865. (PG)
  10. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Chabi S, et al. 2020. Cell Reports. 29(8):2307-2320.e6.. PubMed
  2. Bhattacharya S, et al. 2020. Front Bioeng Biotechnol. 1.055555556. PubMed
  3. Casta?eda-Partida L, et al. 2022. Discov Oncol. 13:28. PubMed
  4. Rendeiro AF, et al. 2020. Nat Commun. 11:577. PubMed
  5. Ivan Jelcic et al. 2018. Cell. 175(1):85-100 . PubMed
  6. Guo X, et al. 2016. Mol Ther Methods Clin Dev. 3:15054. PubMed
  7. Li H, et al. 2022. Front Immunol. 13:988004. PubMed
  8. Keim D, et al. 2021. Int J Mol Sci. 22:. PubMed
  9. Nakano M, et al. 2021. Front Immunol. 12:713225. PubMed
  10. Rochat MA, et al. 2018. Virol J. 15:191. PubMed
  11. Richardson SE, et al. 2021. STAR Protocols. 2(2):100420. PubMed
  12. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  13. Yarzabek B et al. 2018. eLife. 7 pii: e34961. PubMed
  14. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  15. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  16. Turner JS, et al. 2021. Nature. 596:109. PubMed
  17. Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
  18. Li T, et al. 2022. Int J Infect Dis. 122:874. PubMed
  19. Shi Z, et al. 2019. Cell Discov. 0.252777778. PubMed
  20. Kang L, et al. 2020. Exp Hematol Oncol. 9:11. PubMed
  21. Veras FP, et al. 2020. J Exp Med. 217:00:00. PubMed
  22. Alenazy MF, et al. 2021. Sci Rep. 11:5629. PubMed
  23. Wu Y, et al. 2019. Nat Med. 25:776. PubMed
  24. Riboldi E, et al. 2011. J Biol Chem. 286:35329. PubMed
  25. Dai Q, et al. 2020. Front Immunol. 11:539654. PubMed
  26. Alsaleh G, et al. 2020. Elife. 9: . PubMed
  27. Constantinescu-Bercu A, et al. 2020. eLife. 9:00. PubMed
  28. Yin W, et al. 2021. Thorac Cancer. 12:2680. PubMed
  29. Lan X, et al. 2020. Molecular Cell. 81(2):239-254.e8. PubMed
  30. Ramos RN, et al. 2022. Clin Transl Immunology. 11:e1392. PubMed
  31. Urlaub D, et al. 2019. Arthritis Res Ther. 1.067361111. PubMed
  32. Velázquez–Avila M, et al. 2019. Leukemia. 33:1337. PubMed
  33. Alhaj Hussen K, et al. 2017. Immunity. 47:680. PubMed
  34. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  35. Guan J, et al. 2018. Mol Cancer Ther. 17:1090. PubMed
  36. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  37. Caeser R, et al. 2021. Nat Protoc. 16:2499. PubMed
  38. Yang L, et al. 2020. Genes Dis. 7:128. PubMed
  39. Messinger JE, et al. 2019. MBio. 10. PubMed
  40. Nelde A, et al. 2018. Oncoimmunology. 7:e1316438. PubMed
  41. den Hartog G, et al. 2018. Eur J Immunol. 48:283. PubMed
  42. Lee M, et al. 2020. Elife. :9. PubMed
  43. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  44. Mohiuddin M, et al. 2016. Nat Commun. 7: 11138. PubMed
  45. Vabret N, et al. 2022. iScience. 25:104599. PubMed
  46. Lee HJ, et al. 2017. Oncotarget. 8:113345. PubMed
  47. Song R, et al. 2022. Front Immunol. 13:1028246. PubMed
  48. Linedale R, et al. 2017. PLoS One. 12:e0175755. PubMed
  49. Roybal KT et al. 2016. Cell. 167(2):419-432 . PubMed
  50. Benci JL et al. 2019. Cell. 178(4):933-948 . PubMed
  51. Nakachi S, et al. 2017. Arthritis Research & Therapy . 10.1186/s13075-017-1309-x. PubMed
  52. Audigé A, et al. 2017. BMC Immunology. 10.1186/s12865-017-0209-9. PubMed
  53. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  54. Aagaard K, et al. 2017. Sci Rep. 7:41389. PubMed
  55. O'Donoghue GP, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  56. Isobe T, et al. 2022. Nat Commun. 13:4501. PubMed
  57. Zhao NQ, et al. 2020. PLoS One. 15:e0238347. PubMed
  58. Molina MS, et al. 2021. Front Immunol. 12:699128. PubMed
  59. Xu L, et al. 2019. Haematologica. 10.3324/haematol.2018.207258. PubMed
  60. G?rtner K, et al. 2019. J Extracell Vesicles. 8:1573051. PubMed
  61. Lavaert M, et al. 2020. Immunity. 52(6):1088-1104. PubMed
  62. S Tzeng 2016. J Vis Exp. 118:e54582. PubMed
  63. Reyes M, et al. 2021. Sci Transl Med. 13:. PubMed
  64. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  65. Moreno I, et al. 2010. PLoS One. 5:e743. PubMed
  66. Gao P, et al. 2021. Nat Commun. 1194:12. PubMed
  67. Bouvet M, et al. 2021. MBio. 12: . PubMed
  68. Evers M, et al. 2020. MAbs. 12:1795505. PubMed
  69. Alhaj Hussen K, et al. 2020. Front Immunol. 11:579776. PubMed
  70. Yamaguchi K, et al. 2018. Cancer Sci. 109:3032. PubMed
RRID
AB_314241 (BioLegend Cat. No. 302211) AB_314242 (BioLegend Cat. No. 302212)

Antigen Details

Structure
Ig superfamily, type I transmembrane glycoprotein, 95 kD
Distribution

B lineage (except plasma cells), follicular dendritic cells

Function
B cell activation and differentiation
Ligand/Receptor
Forms complex with CD21 (CR2) and CD81 (TAPA-1), BCR coreceptor
Cell Type
B cells, Dendritic cells
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Tedder T, et al. 1994. Immunol. Today 15:437.
2. Bradbury L, et al. 1993. J. Immunol. 151:2915.

Gene ID
930 View all products for this Gene ID
UniProt
View information about CD19 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线